Home > Healthcare > Medical Services > Surgical Services > Aesthetic Medicine Market

Aesthetic Medicine Market - By Type (Surgical Procedures, Non-surgical Procedures) By Product (Energy-based, Non Energy-based), By Gender (Male, Female), By End-use (Hospitals, Beauty Centers & Medical Spas, Dermatology Clinics, Home Settings) & Forecast, 2023 – 2032

  • Report ID: GMI2687
  • Published Date: Apr 2023
  • Report Format: PDF

Aesthetic Medicine Market Size

Aesthetic Medicine Market size surpassed USD 16.75 billion in 2022 and is projected to register over 11.8% CAGR between 2023 and 2032. Growing awareness amongst the healthcare professionals and patients regarding the benefits of aesthetic medicine has positively impacted the market growth. Advancements in surgical and non-surgical aesthetic procedures will also act as primary driver for industry expansion.
 

Aesthetic Medicine Market

Growing inclination towards physical appearance to look young and fit has driven the demand for aesthetic treatment in the developing economies. Aesthetic procedures such as nose reshaping, liposuction, and botulinum toxin injections, that add aesthetic value with minimal invasion, are gaining consumer interest in developing countries. Moreover, collaborative strategies of companies for research and development and rising awareness among population regarding aesthetic medicine will further boost the market growth.
 

Aesthetic medicine mainly focuses on altering cosmetic appearance of the person as per their desire. It is widely conducted to treat conditions such as excess fat, scars, skin discoloration, moles, skin laxity, and wrinkles among others. Aesthetic medicine includes wide range of invasive, minimally invasive and non-invasive cosmetic procedures.
 

Increasing awareness and demand for minimally invasive surgeries will stimulate the industry growth potential in nearby future. Owing to benefits such as reduced risk of infection and relatively less time-consumption with better outcomes are the factors that drive the patient preference for these procedures. Furthermore, technological advancements in aesthetic medicine offers effective solutions for minimally invasive procedures. With continuous developments in the technology towards non-invasive and minimally invasive technology, the aesthetic medicine market is anticipated to foresee unprecedented growth over analysis period. However, due to COVID-19 pandemic, in order to restrict the spread of this contagious disease, government imposed strict lockdown and halt on non-emergency medical procedures. Thus, the industry has experienced moderate impact of coronavirus outbreak and witness gradual recovery with declining prevalence of COVID-19.

Aesthetic Medicine Market Trends

The aesthetic medicine industry is anticipated to foresee unprecedented growth with high adoption of advanced technologies to cater to growing customer needs. With change in lifestyle and increasing consumption of alcohol, smoking and reduced physical activities, the population is suffering from various disorders including obesity. In addition, there is rising body image consciousness among the young population. These factors considerably drive the demand for body contouring and skin tightening procedures. Along with awareness, supportive government initiatives and funding research in the field will stimulate the industry growth potential.
 

Aesthetic Medicine Market Analysis

Aesthetic Medicine Market, by Type

Aesthetic medicine market by type is segmented as non-surgical and surgical. Non-surgical segment held over 64% market share in 2022. With growing introduction of devices for non-surgical aesthetics and population awareness regarding minimally invasive techniques will augment the growth of non-surgical procedures. Innovations in non-invasive procedure technology has led to lesser procedure time with faster recovery which is positively impacting procedure adoption.
 

Non-surgical procedures include facial injectables and, cryolipolysis, among others. Such procedures assist in correcting facial lines, wrinkles, cellulite reduction and reduction of unwanted fat within short time period and with minimal side effects. Furthermore, a considerable increase in desire to overcome the signs of aging has been observed over the past few years. Thus, adoption of non-surgical anti-aging procedures especially by elderly population base will augment the segmental demand.
 

Aesthetic medicine market by product is classified into energy-based and non-energy based. Energy-based is further segmented into laser-based aesthetic device, light-based aesthetic device, radiofrequency (RF)-based aesthetic device, ultrasound aesthetic device and others. Non energy-based includes dermal fillers, botulinum toxin, implants and others. Non energy-based segment is estimated to surpass USD 36.5 billion by 2032. High demand for wide range of non-surgical procedures is supplementing the segment expansion.
 

Increasing disposable income in emerging economies has resulted in adoption of advanced aesthetic medicines. Dermal fillers, being one of the most commonly adopted non-energy-based procedures are used to give volume and fullness to an individual's skin. Moreover, growing demand of facial aesthetics, cost-effectivity and surge in ageing population will further escalate the demand for dermal fillers. Thus, owing to high procedural volume and preference for minimally invasive procedures, the segment will foresee robust growth in forthcoming years.
 

Aesthetic medicine market by gender is classified into male and female. Male and female segment is further classified on the basis of age as 18 years and below,19-34 years, 35-50 years, 51-64 years and 65 years and above. Female segment accounted for more than 79% revenue share in 2022 due to increasing adoption of facial surgeries such as rhinoplasty, blepharoplasty and breast augmentation procedures. Moreover, increasing adoption of breast augmentation procedures among female between 19-34 years of age will foster the demand for breast aesthetics thereby augmenting the market statistics.
 

Aesthetic medicine market by end-use is segregated into hospitals, ambulatory surgical centers, beauty centers and medical spas, dermatology clinics and home settings. Hospitals segment is projected to reach over USD 14.7 billion revenue by 2032. Increasing number of surgeries worldwide and rising expenditure on healthcare infrastructure in emerging economies will enhance the adoption of advanced aesthetic procedures.
 

Requirement of skilled professionals to perform aesthetic procedures, high cost associated with the aesthetic devices and availability of well-developed healthcare facilities will increase the number of procedures in hospitals. Moreover, growing demand for liposuction and abdominoplasty surgery along with high requirement of sophisticated infrastructure and expertise will drive the segmental expansion.
 

Global Aesthetic Medicine Market Size, By Region

North America aesthetic medicine market accounted for over USD 8.6 billion in 2022 and will witness remarkable growth during analysis timeframe due to rising focus on aesthetic appearance, technological advancements and rising inclination of people towards less invasive surgical procedures, primarily in the U.S. Growing adoption of sedentary lifestyle leading to increased incidence of obesity has intensified the demand for fat reduction procedures over the years. Growing expenditure on cosmetic and rejuvenation procedures for enhancing aesthetics is growing rapidly among the people in the region.
 

There are several leading players focusing in the U.S. market. These firms are emphasizing on product innovation collaborations that significantly contributes to the market demand. Due to high awareness and adoption of innovative technologies in the U.S., market players witness momentous growth potential.
 

Aesthetic Medicine Market Share

Some of the Major industry players involved in the aesthetic medicine market include :

  • AbbVie Inc. (Allergan)
  • Galderma
  • Syneron Candela
  • Lumenis, In
  • Merz Pharmaceuticals
  • Alma Lasers
  • Johnson & Johnson
  • PhotoMedex
  • Cutera, Inc.
  • Bausch Health Companies, Inc.
  • and Cynosure 

These industry players are implementing certain strategic initiatives such as collaborations, merger, new product launch & approvals and acquisitions to gain stability and sustainability as well as strengthen their market position.
 

The aesthetic medicine market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report


By Type

  • Surgical
  • Non-surgical

By Product

  • Energy-based
    • Laser-based aesthetic device
    • Radiofrequency (RF)-based aesthetic device
    • Light-based aesthetic device
    • Ultrasound aesthetic device
    • Others
  • Non-Energy-based
    • Botulinum toxin
    • Dermal fillers
    • Implants
      • Facial implants
      • Breast implants
      • Others
    • Others

By Gender

  • Male
    • 18 years and below
    • 19-34 years
    • 35-50 years
    • 51-64 years
    • 65 years and above
  • Female
    • 18 years and below
    • 19-34 years
    • 35-50 years
    • 51-64 years
    • 65 years and above

By End-use

  • Hospitals
  • Ambulatory surgical centers
  • Beauty centers and medical spas
  • Dermatology clinics
  • Home settings

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for aesthetic medicine was valued at more than USD 16.5 billion in 2022 and is set to progress at over 18.5% CAGR over the next 10 years owing to the mounting popularity of aesthetic procedures due to prevalent beauty standards and surging patient demand for non-invasive procedures.

Ambulatory surgical centers segment is anticipated to expand at a 19.5% CAGR over 2023-2032 due to soaring patient preference for shorter stays, cost-effective procedures, and reduced risk of hospital-acquired infections in these facilities.

Non-energy-based segment was valued at more than USD 12.5 billion in 2022 as a result of ongoing technological advancements in non-energy-based medical aesthetic devices intended to offer convenient, effective, and less invasive treatments.

Asia Pacific aesthetic medicine market is projected to reach more than USD 13.5 billion by 2032 as a result of increasing awareness regarding improving beauty standards in the APAC region.

Aesthetic Medicine Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 486
  • Countries covered: 16
  • Pages: 201
 Download PDF